Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?

被引:11
|
作者
Gerard, Alexandre O. [1 ,2 ]
Laurain, Audrey [1 ]
Favre, Guillaume [1 ]
Drici, Milou-Daniel [2 ]
Esnault, Vincent L. M. [1 ]
机构
[1] Univ Cote Azur, Pasteur Hosp, Nephrol Dialysis Transplantat Dept, Nice, France
[2] Univ Cote Azur, Pasteur Hosp, Dept Pharmacol, Nice, France
关键词
D O I
10.2337/dc22-0921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E148 / E149
页数:2
相关论文
共 50 条
  • [31] Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease
    Cheng, Judy W. M.
    Colucci, Vincent
    Kalus, James S.
    Spinler, Sarah A.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (02) : 252 - 260
  • [32] SGLT2 inhibitors in patients with type 2 diabetes and renal disease: overview of current evidence
    Davidson, Jaime A.
    POSTGRADUATE MEDICINE, 2019, 131 (04) : 251 - 260
  • [33] SGLT2 Inhibitors slow down the Progression of chronic Kidney Disease
    不详
    NEPHROLOGE, 2019, 14 (03): : 225 - 225
  • [34] Renal Glucose Handling: Impact of Chronic Kidney Disease (CKD) and SGLT2 Inhibition In Patients With Type 2 Diabetes
    Ferrannini, Ele
    Veltkamp, Stephan A.
    Van Dijk, Jan
    Kadokura, Takeshi
    Smulders, Ronald
    DIABETES, 2012, 61 : A264 - A264
  • [35] SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review
    Maxson, Rebecca
    Starr, Jessica
    Sewell, Jeanna
    Lyas, Claretha
    CLINICAL THERAPEUTICS, 2024, 46 (01) : e23 - e28
  • [36] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Singhal, Rohit
    Hechanova, Lisa Aimee
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
  • [37] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Rohit Singhal
    Lisa Aimee Hechanova
    Current Cardiology Reports, 2022, 24 : 183 - 189
  • [38] SGLT-2 inhibitors in patients with type 2 diabetes with acute kidney disease
    Wu, Vin-Cent
    Pan, Heng-Chih
    Chen, Jui-Yi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I205 - I206
  • [39] SGLT-2 inhibitors in patients with type 2 diabetes with acute kidney disease
    Wu, Vin-Cent
    Pan, Heng-Chih
    Chen, Jui-Yi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [40] Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?
    Qiu, Mei
    Ding, Liang-Liang
    Zhan, Ze-Lin
    Zhou, Hai-Rong
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 87 : 98 - 99